Navigation Links
SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia
Date:11/16/2007

versus placebo in clinical trials for schizophrenia were dry mouth (12% vs 1%), constipation (6% vs 5%), dyspepsia (5% vs 2%), sedation (13% vs 7%), somnolence (12% vs 4%), dizziness (10% vs 4%), headache (7% vs 5%), and orthostatic hypotension (7% vs 5%).

In long-term clinical trials of quetiapine, hyperglycemia (fasting glucose Greater Than or Equal To 126 mg/dl) was observed in 10.7% of patients receiving quetiapine (mean exposure 213 days) vs 4.6% in patients receiving placebo (mean exposure 152 days).

Please see Prescribing Information, including Boxed Warnings, for SEROQUEL and SEROQUEL XR.

About Schizophrenia

Schizophrenia is a serious brain disorder with symptoms including distorted perceptions of reality, hallucinations and delusions, illogical thinking, and flat or blunted emotions.(4) Schizophrenia affects men and women with equal frequency, but the first signs of schizophrenia typically emerge earlier in men (in late teens or early twenties) compared to women (in twenties or early thirties). Approximately 2.4 million American adults -- about 1.1 % of the population age 18 and older -- suffer from schizophrenia.(5) Medications are important in the management of symptoms. While there is no cure for schizophrenia, it is a highly treatable and manageable illness. Medications are classified into two categories -- "conventional" and "atypical" antipsychotics.(7)

About AstraZeneca

AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with healthcare sales of $26.47 billion and leading positions in sales of gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.

In the United States, AstraZen
'/>"/>

SOURCE AstraZeneca
Copyright©2007 PR Newswire.
All rights reserved

5

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
2. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
6. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
7. CryoCor Receives FDA Approval for Right Atrial Flutter
8. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
9. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
10. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
11. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... VIEJO , Kalifornien, 20. Mai 2013 ... bekannt, dass das Unternehmen die CE-Kennzeichnung für ... zur Embolisation von Aneurysmen erhalten hat. Das ... Europa bereits mit der kontrollierten Einführung dieser ... bietet die SL-Produktfamilie auch ein verbessertes Handling, ...
(Date:5/20/2013)... LONDON , BERLIN ... 2013 Arthroscopy Devices Market ... Preference for Minimally Invasive Procedures to Drive Future Growth" ... trends for the six arthroscopy device market segments: arthroscopes, ... arthroscopy radio frequency systems, and arthroscopy visualization systems. The ...
(Date:5/20/2013)... 2013  Neuralstem, Inc. (NYSE MKT: CUR) today reported ... principal investigator, presented updated Phase I data from its ... the treatment of amyotrophic lateral sclerosis (ALS or ... diabetes special medical symposium in Bucharest, Romania ... Therapeutic Advances in Stem Cell Therapy," Dr. Feldman outlined ...
Breaking Medicine Technology:Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 2Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 3Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 2Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 3Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 4Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4
(Date:5/20/2013)... MONDAY, May 20 (HealthDay News) -- A child whose ... relatively higher risk for developing a respiratory infection before ... Researchers looked at data involving nearly 1,300 pairs of ... began study participation while in their first trimester of ... About 6 percent of the mothers lived within 100 ...
(Date:5/20/2013)... In celebration of National Women’s Health Week and ... The Feinstein Institute for Medical Research and ... in Science and Medicine (AWSM) , hosted its second ... business and community leaders from the region attended the ... science. , “Women face unique barriers to success ...
(Date:5/20/2013)... emergency departments play a growing role in the U.S. ... hospital admissions and serving increasingly as an advanced diagnostic ... RAND Corporation study. , While often targeted as the ... remain an important safety net for Americans who cannot ... slowing the growth of health care costs, according to ...
(Date:5/20/2013)... ANN ARBOR, Mich. As high schoolers prepare for ... a "study drug" -- a prescription stimulant or amphetamine ... University of Michigan poll shows only one in 100 ... teen has used a study drug., Study drugs refer ... attention deficit hyperactivity disorder (ADHD); commonly prescribed medicines in ...
(Date:5/20/2013)... 2013) Wolters Kluwer Health is ... Wilkins (LWW) published journals won 13 ASHPE awards ... member articles and publications for editorial, design, print ... honor to be recognized year after year for ... the industry with quality, depth, and impact," said ...
Breaking Medicine News(10 mins):Health News:Living Near Major Roadways in Pregnancy Tied to Respiratory Woes in Children 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 3Health News:Hospital emergency departments gaining in importance, study finds 2Health News:Hospital emergency departments gaining in importance, study finds 3Health News:1 in 10 teens using 'study drugs,' but parents aren't paying attention 2Health News:Wolters Kluwer Health receives 13 awards from the ASHPE 2
... Quad Will Become the Highest-Selling Antiretroviral in the ... from Decision ResourcesWALTHAM, Mass., May 19 Decision ... advisory firms for pharmaceutical and healthcare issues, finds ... six percent annual growth in the HIV drug ...
... ( www.apieron.com ) significantly strengthened its senior ... Vice President, Sales & Marketing, and Bryan Miller as ... Bubrick has more than 20 years of operational and ... in diabetes management. Prior to joining Apieron, Mr. Bubrick ...
... May 19 New Life Agency filed suit against ... contract.This lawsuit grew out of a previous contractual relationship ... in December 2005. Once New Life Agency assumed direct ... for New Life,s Surrogate Maternity and Cycle Medical Plan(R), ...
... Has 6 Front Range LocationsDENVER, May 19 Clinic ... Solutions, announced today the firm has secured an agreement ... to all Front Range MedExpress Urgent Care locations. ... nationwide reach."This is a key new contract for us," ...
... INTERESTS ARE NOT ALIGNED WITH STOCKHOLDERSADVOCAT BOARD NEEDS TO ... May 19 Bristol Investment Fund, Ltd. ("Bristol") announced ... stockholders of Advocat, Inc. (the "Company") (Nasdaq: ... qualified and independent director nominees, Paul Kessler and Richard ...
... be Issued from Among Intradigm,s Large Collection of ... Intradigm Corporation, a leading developer of targeted, ... issuance of United States patent 7,534,878, titled "Composition ... Cancer and Other Neovascularization Diseases." The issued ...
Cached Medicine News:Health News:Sales of Antiretroviral Agents Will Drive Substantial Six Percent Annual Growth in the HIV Drug Market Through 2013 2Health News:Sales of Antiretroviral Agents Will Drive Substantial Six Percent Annual Growth in the HIV Drug Market Through 2013 3Health News:Apieron Strengthens Senior Leadership With Commercial, Financial Appointments 2Health News:New Life Agency, Inc. Continues to Trial Against Beitler Services, Inc. in Pursuit of Payments for Surrogate Maternity Claims 2Health News:New Life Agency, Inc. Continues to Trial Against Beitler Services, Inc. in Pursuit of Payments for Surrogate Maternity Claims 3Health News:Clinic Service Announces Agreement to Provide Billing Service to MedExpress 2Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 2Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 3Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 4Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 5Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 6Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 7Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 8Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 9Health News:Intradigm Announces Issuance of RNA Interference (RNAi) Patent Covering Potent siRNA Sequence 2Health News:Intradigm Announces Issuance of RNA Interference (RNAi) Patent Covering Potent siRNA Sequence 3
... Eppendorf Mastercycler Family offers fast temperature control, ... optimal flexibility. Personal cards enable safe program ... transfer of individual protocols between different Mastercyclers. ... PCR and come with a two-year warranty. ...
... The latest addition to ... thermal cyclers is the personal-sized ... ideal instrument for both basic ... It represents the culmination of ...
... well thermocycler with unique High ... for fastest available heating and ... with High Pressure Lid for ... Includes motorized lid for ...
... highest precision, more user-friendliness and absolute reliability ... the definition of the Mastercycler ep system. ... research has been developing dynamically. The same ... Systems. To keep pace with these ...
Medicine Products: